Pacylex Pharmaceuticals Publishes a New Myristoylation Inhibitor Mechanism of Anti-Cancer Activity in Molecular Cancer Therapeutics ...

Initially mistaken for neutrophils, a population of atypical macrophages appears in the lungs after severe viral infection, ...

This is an important piece of work that sheds light on our understanding of early lung development. There is solid evidence that there is a key new role for Svep1, which may be acting via FGF9. A more ...

Johnson & Johnson stopped short of implementing its proposal to alter the way two drugs are paid for under the 340B drug discount program, but the drugmaker made it clear it still wants changes. In ...

Lung cancer is a major health concern in the Gulf Cooperation Council (GCC) countries, particularly Kuwait and Saudi ...

A peptide synthesized by researchers at the University of São Paulo (USP) in Brazil protected human lung cells against ...

The synthetic peptide was inspired by ACE2, the protein to which the virus that causes COVID-19 binds to invade human cells.

This year marks the 20th anniversary of the first reports of EGFR (epidermal growth factor receptor) mutations and their association with responsiveness to EGFR tyrosine kinase inhibitors. These ...

2022). The K18-hACE2-transgenic mouse model expresses hACE2 under the human keratin 18 (K18) promoter. This model develops a robust respiratory disease that majorly recapitulates severe COVID-19 ...

locally advanced or metastatic epidermal growth factor receptor (EGFR) wild type, nonsquamous non-small cell lung cancer (NSCLC) with c-Met protein overexpression. Approximately 85% of lung ...

Teliso-V is an investigational antibody-drug conjugate (ADC) for patients with previously treated nonsquamous non-small cell lung cancer (NSCLC) with c-Met protein overexpression. - There are ...

AstraZeneca’s TAGRISSO® (osimertinib)​ has been approved in the US for the treatment of adult patients with unresectable, Stage III epidermal growth factor receptor-mutated (EGFRm) non-small cell lung ...